ArticleOncotarget2017

The effect of rapamycin, NVP-BEZ235, aspirin, and metformin on PI3K/AKT/mTOR signaling pathway of PIK3CA-related overgrowth spectrum (PROS).

Yasuyo Suzuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.